← back to dashboard

DARE

Dare Bioscience, Inc.
Composite
0.23
EDGAR
0.23
Filings (90d)
8
Peak
0.28
Last Signal
2026-09-11T16:29

All Filings

Filed Form Items Signal Score Summary Link
2026-09-11 16:29 8-K ["5.03", "9.01"] other 0.62 Bylaw amendment reducing stockholder quorum from majority to one-third; typical pre-transaction defensive maneuver. SEC · detail
2026-09-09 09:00 8-K ["7.01", "9.01"] other 0.15 Routine corporate presentation filing; no M&A-related language or strategic transaction indicators present. SEC · detail
2026-08-17 08:35 8-K ["1.01"] other 0.05 Securities offering (equity financing) with warrants; no M&A transaction indicated. SEC · detail
2026-08-13 16:02 8-K ["2.02", "9.01"] other 0.05 Routine Q2 2026 earnings announcement with no M&A signals, strategic review language, or transaction indicators. SEC · detail
2026-07-24 09:00 8-K ["7.01", "9.01"] other 0.05 Routine disclosure of corporate presentation for investor meetings; no M&A indicators present. SEC · detail
2026-07-17 16:07 8-K ["3.01"] other 0.05 Nasdaq delisting notice due to insufficient stockholders' equity; no M&A signal. SEC · detail
2026-07-13 09:00 8-K ["7.01", "9.01"] other 0.15 Routine corporate presentation filing; no M&A signals or strategic transaction indicators present. SEC · detail
2026-06-22 09:00 8-K ["7.01", "9.01"] other 0.05 Routine 8-K disclosing corporate presentation for investor meetings; no M&A indicators present. SEC · detail
2026-06-12 16:01 8-K ["5.02", "5.07", "9.01"] other 0.05 Routine shareholder meeting with director elections, equity plan amendment, and accounting firm ratification. No M&A signals. SEC · detail
2026-05-18 16:25 8-K ["3.02"] other 0.05 Regulation A equity offering completion; no M&A indicators. SEC · detail
2026-05-14 16:01 8-K ["2.02", "9.01"] other 0.05 Routine earnings announcement for Q1 2026; no M&A signals present. SEC · detail
2026-05-07 16:11 8-K ["3.02"] other 0.05 Regulation A equity offering completion; no M&A signal. SEC · detail